Amping up T cells to target cancer

Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have…

To respect copyright, we link to the source rather than republishing the full text. Read the complete article on MIT Technology Review.